ANIK - Anika Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue105,555113,420103,37992,999
Cost of Revenue31,28027,36424,02721,053
Gross Profit74,27586,05679,35271,946
Operating Expenses
Research Development18,19018,78710,7328,290
Selling General and Administrative28,13621,54018,01314,825
Non Recurring----
Others----
Total Operating Expenses77,60667,69152,77244,168
Operating Income or Loss27,94945,72950,60748,831
Income from Continuing Operations
Total Other Income/Expenses Net-4,742473263-577
Earnings Before Interest and Taxes27,94945,72950,60748,831
Interest Expense----
Income Before Tax23,20746,20250,87048,254
Income Tax Expense4,48514,38618,32317,496
Minority Interest----
Net Income From Continuing Ops18,72231,81632,54730,758
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income18,72231,81632,54730,758
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares18,72231,81632,54730,758